Eisai
4523.T
#2171
Rank
โ‚น796.50 B
Marketcap
โ‚น2,826
Share price
2.53%
Change (1 day)
14.24%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: โ‚น48.42 Billion

According to Eisai's latest financial reports the company's current earnings are โ‚น5.06 Billion. In 2023 the company made an earning of โ‚น48.42 Billion, an increase over its 2022 earnings that were of -โ‚น2.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023โ‚น48.42 B-2404.04%
2022-โ‚น2.11 Billion-103.6%
2021โ‚น58.43 B-39.81%
2020โ‚น97.07 B7.44%
2019โ‚น90.35 B17.22%
2018โ‚น77.08 B86.16%
2017โ‚น41.40 B-23.52%
2016โ‚น54.14 B26.97%
2015โ‚น42.64 B22.3%
2014โ‚น34.86 B-46.07%
2013โ‚น64.65 B-21.85%
2012โ‚น82.72 B-20.59%
2011โ‚น104.17 B-8.91%
2010โ‚น114.37 B19.21%
2009โ‚น95.94 B